ArticleNucleic acids research2026
Toxin dimerization and a distinct DNA-binding architecture define chromosomal Phd-Doc regulation.
Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Toxin-antitoxin (TA) systems are widespread bacterial regulatory modules, yet the structural diversity of chromosomally encoded TA regulation remains incompletely understood. Here, we show that the Enterococcus faecalis Phd-Doc module adopts a regulatory architecture distinct from the canonical Escherichia coli paradigm. Structural analyses reveal that toxin neutralization is associated with antitoxin-mediated toxin dimerization rather than direct occlusion of the conserved catalytic motif. In parallel, the N-terminal domain of E. faecalis Phd forms a β-sheet-based DNA-binding arrangement that recognizes a single palindromic operator, contrasting with the cooperative dual-operator recognition observed in E. coli. Together, these features define an alternative configuration for operator recognition and toxin regulation within a chromosomal TA system. Structure-guided peptide design further demonstrates that the E. faecalis Phd-Doc interface can be selectively perturbed, highlighting the potential of exploiting distinct TA architectures for differential functional modulation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.